Charles River Laboratories International (CRL) Raw Materials (2010 - 2022)
Charles River Laboratories International (CRL) posted Raw Materials of $35.6 million for Q3 2022, down 4.4% on a QoQ basis from $37.2 million in Q2 2022, and up 13.54% year-over-year from $31.4 million in Q3 2021.
Analysis
Charles River Laboratories International (CRL) Raw Materials (2010 - 2022) Analysis & Trends
Charles River Laboratories International has reported Raw Materials for 13 years, with the latest figure at $35.6 million in Q3 2022.
- On a quarterly basis, Raw Materials rose 13.54% year-over-year to $35.6 million in Q3 2022; TTM through Sep 2022 was $35.6 million, a 13.54% increase from a year earlier, with the FY2021 full-year figure at $33.1 million, up 16.95% from the prior year.
- Raw Materials was $35.6 million for Q3 2022 at Charles River Laboratories International, down from $37.2 million in the prior quarter.
- The five-year high for Raw Materials was $37.2 million in Q2 2022, with the low at $20.4 million in Q1 2018.
- Average Raw Materials over 5 years is $27.2 million, with a median of $25.1 million recorded in 2020.
- The sharpest annual moves came in 2020 and 2022: Raw Materials grew 3.09% in 2020, then soared 30.07% in 2022.
- Over 5 years, Raw Materials stood at $22.4 million in 2018, then rose by 9.99% to $24.6 million in 2019, then climbed by 15.05% to $28.3 million in 2020, then increased by 16.95% to $33.1 million in 2021, then grew by 7.49% to $35.6 million in 2022.
- The last three Raw Materials figures came in at $35.6 million (Q3 2022), $37.2 million (Q2 2022), and $34.8 million (Q1 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 24, 2022 | 35.60 Mn |
| Jun 25, 2022 | 37.24 Mn |
| Mar 26, 2022 | 34.76 Mn |
| Dec 25, 2021 | 33.12 Mn |
| Sep 25, 2021 | 31.35 Mn |
| Jun 26, 2021 | 32.07 Mn |
| Mar 27, 2021 | 26.73 Mn |
| Dec 26, 2020 | 28.32 Mn |
| Jun 27, 2020 | 25.43 Mn |
| Mar 28, 2020 | 24.71 Mn |
| Dec 28, 2019 | 24.61 Mn |
| Sep 28, 2019 | 23.67 Mn |
| Jun 29, 2019 | 24.67 Mn |
| Mar 30, 2019 | 22.12 Mn |
| Dec 29, 2018 | 22.38 Mn |
| Sep 29, 2018 | 20.80 Mn |
| Jun 30, 2018 | 21.16 Mn |
| Mar 31, 2018 | 20.35 Mn |
| Dec 30, 2017 | 19.86 Mn |
| Sep 30, 2017 | 19.26 Mn |